-
1
-
-
17344383981
-
Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies
-
Barnett JM, Cadman A, Gor D, Dempsey M, Walters M, Candlin A, Tisdale M, Morley PJ, Owens IJ, Fenton RJ, Lewis AP, Claas ECJ, Rimmelzwaan GF, de Groot R, Osterhaus ADME (2000) Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob Agents Chemother 44: 78-87.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 78-87
-
-
Barnett, J.M.1
Cadman, A.2
Gor, D.3
Dempsey, M.4
Walters, M.5
Candlin, A.6
Tisdale, M.7
Morley, P.J.8
Owens, I.J.9
Fenton, R.J.10
Lewis, A.P.11
Claas, E.C.J.12
Rimmelzwaan, G.F.13
de Groot, R.14
Osterhaus, A.D.M.E.15
-
2
-
-
84863411345
-
Molecular and antigenic characterization of reassortant H3N2 - viruses from turkeys with a unique constellation of pandemic H1N1 Internal Genes
-
Berhane Y, Kehler H, Handel K, Hisanaga T, Xu W, Ojkic D, Pasick J (2012) Molecular and antigenic characterization of reassortant H3N2 - viruses from turkeys with a unique constellation of pandemic H1N1 Internal Genes. PLoS ONE 7: e32858.
-
(2012)
PLoS ONE
, vol.7
-
-
Berhane, Y.1
Kehler, H.2
Handel, K.3
Hisanaga, T.4
Xu, W.5
Ojkic, D.6
Pasick, J.7
-
3
-
-
77952576118
-
Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
-
Davies BE (2010) Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemother 65 (Suppl 2): ii5-10.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. ii5-10
-
-
Davies, B.E.1
-
4
-
-
29144528757
-
Oseltamivir resistance during treatment of influenza A (H5N1) infection
-
de Jong MD, Thanh TT, Truong HK, Hien VM, Smith GJD, Chau NV, Cam BV, Qui PT, Ha DQ, Guan Y, Malik Peiris JS, Hien TT, Farrar J (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353: 2667-2672.
-
(2005)
N Engl J Med
, vol.353
, pp. 2667-2672
-
-
de Jong, M.D.1
Thanh, T.T.2
Truong, H.K.3
Hien, V.M.4
Smith, G.J.D.5
Chau, N.V.6
Cam, B.V.7
Qui, P.T.8
Ha, D.Q.9
Guan, Y.10
Malik Peiris, J.S.11
Hien, T.T.12
Farrar, J.13
-
5
-
-
77953258396
-
Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design
-
Durrant JD, McCammon JA (2010) Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design. Comp Biol Chem 34: 97-105.
-
(2010)
Comp Biol Chem
, vol.34
, pp. 97-105
-
-
Durrant, J.D.1
McCammon, J.A.2
-
6
-
-
67349090612
-
Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt
-
Earhart KC, Elsayed NM, Saad MD, Gubareva LV, Nayel A, Deyde VM, Abdelsattar A, Abdelghani AS, Boynton BR, Mansour MM, Essmat HM, Klimov A, Shuck-Lee D, Monteville MR, Tjaden JA (2009) Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt. J Infect Public Health 2: 74-80.
-
(2009)
J Infect Public Health
, vol.2
, pp. 74-80
-
-
Earhart, K.C.1
Elsayed, N.M.2
Saad, M.D.3
Gubareva, L.V.4
Nayel, A.5
Deyde, V.M.6
Abdelsattar, A.7
Abdelghani, A.S.8
Boynton, B.R.9
Mansour, M.M.10
Essmat, H.M.11
Klimov, A.12
Shuck-Lee, D.13
Monteville, M.R.14
Tjaden, J.A.15
-
7
-
-
84864754428
-
Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 virus
-
Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K (2012) Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 virus. PLoS ONE 7: e42419.
-
(2012)
PLoS ONE
, vol.7
-
-
Fukushi, M.1
Yamashita, M.2
Miyoshi-Akiyama, T.3
Kubo, S.4
Yamamoto, K.5
Kudo, K.6
-
8
-
-
33845462128
-
Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A(H3N2) influenza virus in mice
-
Galabov AS, Simeonova L, Gegova G (2006) Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A(H3N2) influenza virus in mice. Antivir Chem Chemother 17: 251-258.
-
(2006)
Antivir Chem Chemother
, vol.17
, pp. 251-258
-
-
Galabov, A.S.1
Simeonova, L.2
Gegova, G.3
-
9
-
-
84867692130
-
Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission
-
Ghedin E, Holmes EC, DePasse JV, Pinilla LT, Fitch A, Hamelin ME, Papenburg J, Boivin G (2012) Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission. J Infect Dis 206: 1504-1511.
-
(2012)
J Infect Dis
, vol.206
, pp. 1504-1511
-
-
Ghedin, E.1
Holmes, E.C.2
DePasse, J.V.3
Pinilla, L.T.4
Fitch, A.5
Hamelin, M.E.6
Papenburg, J.7
Boivin, G.8
-
10
-
-
9644262504
-
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-inflfluenza virus effects in MDCK Cells
-
Govorkova EA, Fang HB, Tan M, Webster RG (2004) Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-inflfluenza virus effects in MDCK Cells. Antimicrob Agents Chemother 48: 4855-4863.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 4855-4863
-
-
Govorkova, E.A.1
Fang, H.B.2
Tan, M.3
Webster, R.G.4
-
11
-
-
0034801450
-
Comparison of efficacies od RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and other avian influenza viruses
-
Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG (2001) Comparison of efficacies od RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother 45: 2723-2732.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2723-2732
-
-
Govorkova, E.A.1
Leneva, I.A.2
Goloubeva, O.G.3
Bush, K.4
Webster, R.G.5
-
12
-
-
0035190544
-
Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
-
Gubareva LV, Webster RG, Hayden FG (2001) Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother 45: 3403-3408.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 3403-3408
-
-
Gubareva, L.V.1
Webster, R.G.2
Hayden, F.G.3
-
13
-
-
57749187455
-
Developing new antiviral agents for inflfluenza treatment: what does the future hold?
-
Hayden F (2009) Developing new antiviral agents for inflfluenza treatment: what does the future hold? Clin Infect Dis 48 (Suppl 1): S3-S13.
-
(2009)
Clin Infect Dis
, vol.48
, pp. S3-S13
-
-
Hayden, F.1
-
14
-
-
30444457092
-
Neuraminidase Inhibitor Susceptibility Network position statement: antiviral resistance in influenza A/H5N1 viruses
-
Hayden F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, Macken C, Hampson A, Webster RG, Amyard M, Zambon M (2005) Neuraminidase Inhibitor Susceptibility Network position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir Ther 10: 873-877.
-
(2005)
Antivir Ther
, vol.10
, pp. 873-877
-
-
Hayden, F.1
Klimov, A.2
Tashiro, M.3
Hay, A.4
Monto, A.5
McKimm-Breschkin, J.6
Macken, C.7
Hampson, A.8
Webster, R.G.9
Amyard, M.10
Zambon, M.11
-
15
-
-
79952182888
-
Antiviral strategies for pandemic and seasonal influenza
-
Hedlund M, Larson JL, Fang F (2010) Antiviral strategies for pandemic and seasonal influenza. Viruses 2: 1766-1781. http://www.who.int/mediacentre/factsheets/avian_influenza/en/. http://www.who.int/mediacentre/factsheets/fs211/en/.
-
(2010)
Viruses
, vol.2
, pp. 1766-1781
-
-
Hedlund, M.1
Larson, J.L.2
Fang, F.3
-
16
-
-
84907681693
-
-
http://www.who.int/mediacentre/factsheets/fs211/en/
-
-
-
-
17
-
-
84907696844
-
-
http://www.who.int/mediacentre/factsheets/avian_influenza/en/
-
-
-
-
18
-
-
67349139846
-
Emergence and spread of oseltamivir-resistant A(H1N1) inflfluenza viruses in Oceania, South East Asia and South Africa
-
Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A, Barr IG (2009a) Emergence and spread of oseltamivir-resistant A(H1N1) inflfluenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83: 90-93.
-
(2009)
Antiviral Res
, vol.83
, pp. 90-93
-
-
Hurt, A.C.1
Ernest, J.2
Deng, Y.M.3
Iannello, P.4
Besselaar, T.G.5
Birch, C.6
Buchy, P.7
Chittaganpitch, M.8
Chiu, S.C.9
Dwyer, D.10
Guigon, A.11
Harrower, B.12
Kei, I.P.13
Kok, T.14
Lin, C.15
McPhie, K.16
Mohd, A.17
Olveda, R.18
Panayotou, T.19
Rawlinson, W.20
Scott, L.21
Smith, D.22
D'Souza, H.23
Komadina, N.24
Shaw, R.25
Kelso, A.26
Barr, I.G.27
more..
-
19
-
-
71849086651
-
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses
-
Hurt AC, Holien JK, Parker MW, Barr IG (2009b) Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs 69: 2523-2531.
-
(2009)
Drugs
, vol.69
, pp. 2523-2531
-
-
Hurt, A.C.1
Holien, J.K.2
Parker, M.W.3
Barr, I.G.4
-
20
-
-
84861959362
-
In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain
-
Hussain Basha S, Prasad RN (2012) In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. BMC Res Notes 5: 105.
-
(2012)
BMC Res Notes
, vol.5
, pp. 105
-
-
Hussain Basha, S.1
Prasad, R.N.2
-
21
-
-
77149156604
-
Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Inflfluenza Virus Activity after a Single Administration
-
Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, Yamashita M (2010) Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Inflfluenza Virus Activity after a Single Administration. Antimicrob Agents Chemother 54: 1256-1264.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1256-1264
-
-
Kubo, S.1
Tomozawa, T.2
Kakuta, M.3
Tokumitsu, A.4
Yamashita, M.5
-
22
-
-
77949322792
-
The substances active against influenza virus. Possibilities and prospects of application
-
(in Polish)
-
Kwiatek M, Kocik J, Bartoszcze M (2009) The substances active against influenza virus. Possibilities and prospects of application. Przegl Epidemiol 63: 487-494 (in Polish).
-
(2009)
Przegl Epidemiol
, vol.63
, pp. 487-494
-
-
Kwiatek, M.1
Kocik, J.2
Bartoszcze, M.3
-
23
-
-
0028935290
-
Microculture virus titration - a simple colourimetric assay for influenza virus titration
-
Levi R, Beeor-Tzahar T, Arnon R (1995) Microculture virus titration - a simple colourimetric assay for influenza virus titration. J Virol Methods 52: 55-64.
-
(1995)
J Virol Methods
, vol.52
, pp. 55-64
-
-
Levi, R.1
Beeor-Tzahar, T.2
Arnon, R.3
-
24
-
-
70349484061
-
Rational design of Tamiflflu derivatives targeting at the open conformation of neuraminidase subtype 1
-
Li Y, Zhou B, Wang R (2009) Rational design of Tamiflflu derivatives targeting at the open conformation of neuraminidase subtype 1. J Mol Graphics Modell 28: 203-219.
-
(2009)
J Mol Graphics Modell
, vol.28
, pp. 203-219
-
-
Li, Y.1
Zhou, B.2
Wang, R.3
-
25
-
-
33749406667
-
Various sides of influenza, part I - Structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics
-
(in Polish)
-
Machala MK, Brydak LB (2006) Various sides of influenza, part I - Structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics. Pol Merk Lek XXI: 123, 270 (in Polish).
-
(2006)
Pol Merk Lek XXI
, vol.123
, pp. 270
-
-
Machala, M.K.1
Brydak, L.B.2
-
26
-
-
68949195871
-
In vitro antiviral of "Nanosilver" on influenza virus
-
Mehrbod P, Motamed N, Tabatabaian M, Soleimani Estyar R, Amini E, Shahidi M, Kheiri MT (2009) In vitro antiviral of "Nanosilver" on influenza virus. DARU 17: 88-93.
-
(2009)
DARU
, vol.17
, pp. 88-93
-
-
Mehrbod, P.1
Motamed, N.2
Tabatabaian, M.3
Soleimani Estyar, R.4
Amini, E.5
Shahidi, M.6
Kheiri, M.T.7
-
27
-
-
84866434839
-
Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012
-
pii
-
Meijer A, Jonges M, van Beek P, Swaan CM, Osterhaus AD, Daniels RS, Hurt AC, Koopmans MP (2012) Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill 17: pii=20266.
-
(2012)
Euro Surveill
, vol.17
, pp. 20266
-
-
Meijer, A.1
Jonges, M.2
van Beek, P.3
Swaan, C.M.4
Osterhaus, A.D.5
Daniels, R.S.6
Hurt, A.C.7
Koopmans, M.P.8
-
28
-
-
58649090243
-
On the structure-based design of novel inhibitors of H5N1 inflfluenza A virus neuraminidase (NA)
-
Mitrasinovic PM (2009) On the structure-based design of novel inhibitors of H5N1 inflfluenza A virus neuraminidase (NA). Biophys Chem 140: 35-38.
-
(2009)
Biophys Chem
, vol.140
, pp. 35-38
-
-
Mitrasinovic, P.M.1
-
29
-
-
76749102845
-
Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus
-
Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DKM, Cheng CKY, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM (2010) Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 50: 707-714.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 707-714
-
-
Ng, S.1
Cowling, B.J.2
Fang, V.J.3
Chan, K.H.4
Ip, D.K.M.5
Cheng, C.K.Y.6
Uyeki, T.M.7
Houck, P.M.8
Malik Peiris, J.S.9
Leung, G.M.10
-
30
-
-
70349331605
-
Triple combination of Amantadine, Ribavirin, and Oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro
-
Nguyen JT, Hoopes JD, Le MH, Smee DF, Patick AK, Faix DJ, Blair PJ, de Jong MD, Prichard MN, Went GT (2010) Triple combination of Amantadine, Ribavirin, and Oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. Antimicrob Agents Chemother 53: 4115-4126.
-
(2010)
Antimicrob Agents Chemother
, vol.53
, pp. 4115-4126
-
-
Nguyen, J.T.1
Hoopes, J.D.2
Le, M.H.3
Smee, D.F.4
Patick, A.K.5
Faix, D.J.6
Blair, P.J.7
de Jong, M.D.8
Prichard, M.N.9
Went, G.T.10
-
31
-
-
61349156679
-
A novel asymmetric synthesis of oseltamivir phosphate (Tamiflflu) from (-)-shikimic acid
-
Nie LD, Shi XX (2009) A novel asymmetric synthesis of oseltamivir phosphate (Tamiflflu) from (-)-shikimic acid. Tetrahedron: Asymmetry 20: 124-129.
-
(2009)
Tetrahedron: Asymmetry
, vol.20
, pp. 124-129
-
-
Nie, L.D.1
Shi, X.X.2
-
32
-
-
79952163859
-
Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective
-
Okomo-Adhiambo M, Sleeman K, Ballenger K, Nguyen HT, Mishin VP, Sheu TG, Smagala J, Li Y, Klimov AI, Gubareva LV (2010) Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective. Viruses 2: 2269-2289.
-
(2010)
Viruses
, vol.2
, pp. 2269-2289
-
-
Okomo-Adhiambo, M.1
Sleeman, K.2
Ballenger, K.3
Nguyen, H.T.4
Mishin, V.P.5
Sheu, T.G.6
Smagala, J.7
Li, Y.8
Klimov, A.I.9
Gubareva, L.V.10
-
33
-
-
73549091448
-
Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus
-
Park JW, Jo WH (2010) Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus. Eur J Med Chem 45: 536-541.
-
(2010)
Eur J Med Chem
, vol.45
, pp. 536-541
-
-
Park, J.W.1
Jo, W.H.2
-
34
-
-
80053131385
-
Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand
-
Payungporn S, Poomipak W, Makkoch J, Rianthavorn P, Theamboonlers A, Poovorawan Y (2011) Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand. J Virol Methods 177: 133-139.
-
(2011)
J Virol Methods
, vol.177
, pp. 133-139
-
-
Payungporn, S.1
Poomipak, W.2
Makkoch, J.3
Rianthavorn, P.4
Theamboonlers, A.5
Poovorawan, Y.6
-
35
-
-
62349104787
-
Design of oseltamivir analogs inhibiting neuraminidase of avian inflfluenza virus H5N1
-
Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S (2009) Design of oseltamivir analogs inhibiting neuraminidase of avian inflfluenza virus H5N1. Antiviral Res 82: 51-58.
-
(2009)
Antiviral Res
, vol.82
, pp. 51-58
-
-
Rungrotmongkol, T.1
Frecer, V.2
De-Eknamkul, W.3
Hannongbua, S.4
Miertus, S.5
-
36
-
-
0037951723
-
Frequency of amantadine-resistant inflfluenza A viruses during Two seasons featuring cocirculation of H1N1 and H3N2
-
Saito R, Sakai T, Sato I, Sano Y, Oshitani H, Sato M, Suzuki H (2003) Frequency of amantadine-resistant inflfluenza A viruses during Two seasons featuring cocirculation of H1N1 and H3N2. J Clin Microbiol 41: 2165-2165.
-
(2003)
J Clin Microbiol
, vol.41
, pp. 2165-2165
-
-
Saito, R.1
Sakai, T.2
Sato, I.3
Sano, Y.4
Oshitani, H.5
Sato, M.6
Suzuki, H.7
-
38
-
-
50949106863
-
Surveillance for neuraminidase inhibitor resistance among human Influenza A and B viruses circulating worldwide from 2004-2008
-
Sheu TG, Deyde VM, Okomo-Adhiambo M, Gerten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human Influenza A and B viruses circulating worldwide from 2004-2008. Antimicrob Agents Chemother 52: 3284-3292.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 3284-3292
-
-
Sheu, T.G.1
Deyde, V.M.2
Okomo-Adhiambo, M.3
Gerten, R.J.4
Xu, X.5
Bright, R.A.6
Butler, E.N.7
Wallis, T.R.8
Klimov, A.I.9
Gubareva, L.V.10
-
39
-
-
34547209215
-
Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo
-
Shi L, Xiong H, He J, Deng H, Li Q, Zhong Q, Hou W, Cheng L, Xiao H, Yang Z (2007) Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo." Arch Virol 158: 1447-1455.
-
(2007)
Arch Virol
, vol.158
, pp. 1447-1455
-
-
Shi, L.1
Xiong, H.2
He, J.3
Deng, H.4
Li, Q.5
Zhong, Q.6
Hou, W.7
Cheng, L.8
Xiao, H.9
Yang, Z.10
-
40
-
-
66149113991
-
Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on inflfluenza A (H5N1) virus infections in cell culture and in mice
-
Smee DF, Hurst BL, Wong MH, Bailey KW, Morrey JD (2009) Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on inflfluenza A (H5N1) virus infections in cell culture and in mice. Antimicrob Agents Chemother 53: 2120-2128.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2120-2128
-
-
Smee, D.F.1
Hurst, B.L.2
Wong, M.H.3
Bailey, K.W.4
Morrey, J.D.5
-
41
-
-
73849083795
-
Effects of the combination of Favipiravir (T-705) and Oseltamivir on influenza A virus infections in mice
-
Smee DF, Hurst BL, Wong MH, Bailey KW, Tarbet EB, Morrey JD, Furuta Y (2010) Effects of the combination of Favipiravir (T-705) and Oseltamivir on influenza A virus infections in mice. Antimicrob Agents Chemother 54: 126-133.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 126-133
-
-
Smee, D.F.1
Hurst, B.L.2
Wong, M.H.3
Bailey, K.W.4
Tarbet, E.B.5
Morrey, J.D.6
Furuta, Y.7
-
42
-
-
0036016097
-
Peramivir (BCX-1812, RWJ-27-270202): potential new therapy for influenza
-
Smee DF, Sidwell RW (2002) Peramivir (BCX-1812, RWJ-27-270202): potential new therapy for influenza. Expert Opin Investig Drugs 11: 859-869.
-
(2002)
Expert Opin Investig Drugs
, vol.11
, pp. 859-869
-
-
Smee, D.F.1
Sidwell, R.W.2
-
43
-
-
70450198610
-
Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein
-
Triana-Baltzer GB, Gubareva LV, Klimov AI, Wurtman DF, Moss RB, Hedlund M, Larson JL, Belshe RB, Fang F (2009) Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS ONE 4: e7838.
-
(2009)
PLoS ONE
, vol.4
-
-
Triana-Baltzer, G.B.1
Gubareva, L.V.2
Klimov, A.I.3
Wurtman, D.F.4
Moss, R.B.5
Hedlund, M.6
Larson, J.L.7
Belshe, R.B.8
Fang, F.9
-
44
-
-
80053090644
-
Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition
-
Vavricka CJ, Li Q, Wu Y, Qi J, Wang M, Liu Y, Gao F, Liu J, Feng E, He J, Wang J, Liu H., Jiang H, Gao GF (2011) Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS ONE 7: e1002249.
-
(2011)
PLoS ONE
, vol.7
-
-
Vavricka, C.J.1
Li, Q.2
Wu, Y.3
Qi, J.4
Wang, M.5
Liu, Y.6
Gao, F.7
Liu, J.8
Feng, E.9
He, J.10
Wang, J.11
Liu, H.12
Jiang, H.13
Gao, G.F.14
-
45
-
-
77957817349
-
Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of inflfluenza virus
-
Wang SQ, Cheng XC, Dong WL, Wang RL, Chou KC (2010) Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of inflfluenza virus. Biochem Biophysi Res Commun 401: 188-191.
-
(2010)
Biochem Biophysi Res Commun
, vol.401
, pp. 188-191
-
-
Wang, S.Q.1
Cheng, X.C.2
Dong, W.L.3
Wang, R.L.4
Chou, K.C.5
-
46
-
-
33646478266
-
In vitro efficacies of Oseltamivir carboxylate and Zanamivir against equine influenza A viruses
-
Yamanaka T, Tsujimura K, Kondo T, Matsumura T (2006) In vitro efficacies of Oseltamivir carboxylate and Zanamivir against equine influenza A viruses. J Vet Med Sci 68: 405-408.
-
(2006)
J Vet Med Sci
, vol.68
, pp. 405-408
-
-
Yamanaka, T.1
Tsujimura, K.2
Kondo, T.3
Matsumura, T.4
|